California Pacific Medical Center's Liver Disease Management & Transplant Program offers complete evaluation and assessment for adult end-stage liver disease and transplant patients. We evaluate more than 1,000 patients annually, emphasizing early referral before multiple or advanced complications develop due to liver disease.

Our hepatologists are nationally renowned for their research efforts. Studies of Hepatitis B and C, liver cancer and liver transplant innovations are continually being pursued in our research center.

In the U.S., the most common causes of chronic liver disease--and reasons for referral to a liver disease management and transplant program--include:
> alcohol damage
> hepatitis viruses (especially hepatitis B and hepatitis C)
> fatty liver
> medications
> hemochromatosis (too much iron in the liver)

Other causes of liver disease and cirrhosis include autoimmune hepatitis (a condition in which a patient's immune cells attack the liver); primary biliary cirrhosis (an autoimmune disease in which the bile tubes that drain bile from the liver are attacked); primary sclerosing cholangitis (a disease in which the bile tubes become blocked); alpha-1 antitrypsin deficiency (this enzyme protects the lung from destruction) and Wilson's disease (too much copper in the liver). For more information on these conditions, see our patient topics.

At California Pacific, we work with gastroenterologists and internal medicine physicians throughout Northern California and Nevada to help manage patients with end-stage liver disease. For further information, contact us.